Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Sinakos

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Current Pharmaceutical Design|August 6, 2025
FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical DataChrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 2, 2009
Gastrointestinal stromal tumors: a pictorial reviewDanai Chourmouzi, Emmanouil Sinakos, Lavrentis Papalavrentios, et al.
Annals of Gastroenterology|April 10, 2014
The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrenceEmmanouil Sinakos, Gennaro Selvaggi, Lavrentis Papalavrentios, et al.
Annals of Hepatology|October 14, 2019
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?Stefania Kiapidou, Christina Liava, Maria Kalogirou, et al.
Hormones (Athens, Greece)|December 19, 2025
Dual target, dual benefit: real-world effects of SGLT2 inhibitors and GLP-1 receptor agonists on the FIB-4 score in people with type 2 diabetes mellitusVirginia Markoutsaki, Georgios Dimakopoulos, Emmanouil Sinakos, et al.
Annals of Gastroenterology|September 5, 2022
Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?Ioanna Papagiouvanni, Pantelis Sarafidis, Marieta P Theodorakopoulou, et al.
Journal of Gastroenterology and Hepatology|March 15, 2012
Pathogenesis and management of pruritus in cholestatic liver diseaseMohamad H Imam, Andrea A Gossard, Emmanouil Sinakos, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|August 7, 2013
Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomySombat Treeprasertsuk, Einar Björnsson, Emmanouil Sinakos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 6, 2011
Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosisNjideka Momah, Marina G Silveira, Roberta Jorgensen, et al.
Clinics and Research in Hepatology and Gastroenterology|December 14, 2020
Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trialsMaria-Styliani Kalogirou, Dimitrios Patoulias, Anna-Bettina Haidich, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|August 6, 2025
FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical DataChrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 2, 2009
Gastrointestinal stromal tumors: a pictorial reviewDanai Chourmouzi, Emmanouil Sinakos, Lavrentis Papalavrentios, et al.
Annals of Gastroenterology|April 10, 2014
The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrenceEmmanouil Sinakos, Gennaro Selvaggi, Lavrentis Papalavrentios, et al.
Annals of Hepatology|October 14, 2019
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?Stefania Kiapidou, Christina Liava, Maria Kalogirou, et al.
Hormones (Athens, Greece)|December 19, 2025
Dual target, dual benefit: real-world effects of SGLT2 inhibitors and GLP-1 receptor agonists on the FIB-4 score in people with type 2 diabetes mellitusVirginia Markoutsaki, Georgios Dimakopoulos, Emmanouil Sinakos, et al.
Annals of Gastroenterology|September 5, 2022
Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?Ioanna Papagiouvanni, Pantelis Sarafidis, Marieta P Theodorakopoulou, et al.
Journal of Gastroenterology and Hepatology|March 15, 2012
Pathogenesis and management of pruritus in cholestatic liver diseaseMohamad H Imam, Andrea A Gossard, Emmanouil Sinakos, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|August 7, 2013
Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomySombat Treeprasertsuk, Einar Björnsson, Emmanouil Sinakos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 6, 2011
Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosisNjideka Momah, Marina G Silveira, Roberta Jorgensen, et al.
Clinics and Research in Hepatology and Gastroenterology|December 14, 2020
Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trialsMaria-Styliani Kalogirou, Dimitrios Patoulias, Anna-Bettina Haidich, et al.
Pageof 6